1. Home
  2. ELTX vs PBHC Comparison

ELTX vs PBHC Comparison

Compare ELTX & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • PBHC
  • Stock Information
  • Founded
  • ELTX 2011
  • PBHC 1859
  • Country
  • ELTX United States
  • PBHC United States
  • Employees
  • ELTX N/A
  • PBHC N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • PBHC Major Banks
  • Sector
  • ELTX Health Care
  • PBHC Finance
  • Exchange
  • ELTX Nasdaq
  • PBHC Nasdaq
  • Market Cap
  • ELTX 121.7M
  • PBHC 93.1M
  • IPO Year
  • ELTX N/A
  • PBHC N/A
  • Fundamental
  • Price
  • ELTX $5.57
  • PBHC $14.78
  • Analyst Decision
  • ELTX Strong Buy
  • PBHC
  • Analyst Count
  • ELTX 2
  • PBHC 0
  • Target Price
  • ELTX $9.50
  • PBHC N/A
  • AVG Volume (30 Days)
  • ELTX 34.1K
  • PBHC 4.6K
  • Earning Date
  • ELTX 05-19-2025
  • PBHC 04-30-2025
  • Dividend Yield
  • ELTX N/A
  • PBHC 2.72%
  • EPS Growth
  • ELTX N/A
  • PBHC N/A
  • EPS
  • ELTX N/A
  • PBHC 0.72
  • Revenue
  • ELTX N/A
  • PBHC $41,317,000.00
  • Revenue This Year
  • ELTX N/A
  • PBHC N/A
  • Revenue Next Year
  • ELTX N/A
  • PBHC N/A
  • P/E Ratio
  • ELTX N/A
  • PBHC $20.51
  • Revenue Growth
  • ELTX N/A
  • PBHC 1.46
  • 52 Week Low
  • ELTX $3.34
  • PBHC $12.05
  • 52 Week High
  • ELTX $11.45
  • PBHC $19.86
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 51.02
  • PBHC 43.82
  • Support Level
  • ELTX $4.85
  • PBHC $13.71
  • Resistance Level
  • ELTX $5.75
  • PBHC $15.04
  • Average True Range (ATR)
  • ELTX 0.49
  • PBHC 0.27
  • MACD
  • ELTX 0.14
  • PBHC 0.04
  • Stochastic Oscillator
  • ELTX 70.28
  • PBHC 60.92

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

Share on Social Networks: